Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Clinical Practice

Drug-eluting stents (DES) reduce the need for repeat target revascularization (TVR) compared with bare metal stents (BMS) but are more costly. The objective was to evaluate the cost-effectiveness of DES versus BMS. We evaluated clinical outcomes and costs of care over 3 years in 1147 undergoing BMS...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation Cardiovascular quality and outcomes 2011-07, Vol.4 (4), p.408-415
Hauptverfasser:	SCHAFER, Pascha E, SACRINTY, Matthew T, COHEN, David J, KUTCHER, Michael A, GANDHI, Sanjay K, SANTOS, Renato M, LITTLE, William C, APPLEGATE, Robert J
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - physiopathology Acute Coronary Syndrome - therapy Aged Biological and medical sciences Blood Vessel Prosthesis Implantation Coronary Restenosis - etiology Coronary Restenosis - prevention & control Cost-Benefit Analysis Diseases of the cardiovascular system Drug-Eluting Stents - adverse effects Drug-Eluting Stents - economics Female Follow-Up Studies Humans Male Medical sciences Middle Aged Paclitaxel - therapeutic use Postoperative Complications Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Sirolimus - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!